4//SEC Filing
Bridger Gary 4
Accession 0000899243-19-007832
CIK 0001501697other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 9:38 PM ET
Size
6.2 KB
Accession
0000899243-19-007832
Insider Transaction Report
Form 4
Bridger Gary
Director
Transactions
- Award
Stock Option (right to buy)
2019-03-13+21,570→ 21,570 totalExercise: $10.44Exp: 2028-10-03→ Common Stock (21,570 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on October 4, 2019, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Reflects the Reporting Person's stock option to acquire 226,983 shares of X4 common stock for $0.99 per share that was assumed by the Issuer in the merger of Artemis AC Corp., a wholly-owned subsidiary of the Issuer, with and into X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) ("X4") on March 13, 2019 (the "Merger").
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001600049
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 9:38 PM ET
- Size
- 6.2 KB